2007 BIO InvestorForum - Presenting Companies

Presenting Companies

Listed below are the companies that were selected to present at the 2007 BIO InvestorForum.

To view presenting companies by category, please click here.

ACADIA Pharmaceuticals Inc. (NASDAQ : ACAD)

Accera, Inc.

Aciont Inc

Acologix, Inc.

Acusphere, Inc. (Nasdaq : ACUS)

ADVENTRX Pharmaceuticals. (AMEX : ANX)

Aequus BioPharma, Inc.

Aerovance, Inc.

Affymax, Inc. (NasdaqGM : AFFY)

Agile Therapeutics, Inc.

Akesis Pharmaceuticals (BB-OTC : AKES.OB)

Alacrity Biosciences

Alba Therapeutics Corporation

Alexza Pharmaceuticals, Inc. (NASDAQ : ALXA)

Alfacell Corporation (Nasdaq : ACEL)

Algeta ASA (Oslo stock exchange : ALGETA)

Allon Therapeutics Inc. (TSX : NPC)

Alnylam Pharmaceuticals, Inc. (NasdaqGM : ALNY)

Alseres Pharmaceuticals, Inc. (NASDAQ : ALSE)

Amarin Corporation plc (NASDAQ : AMRN)

Ambit

Anadys Pharmaceuticals, Inc. (NasdaqGM : ANDS)

Anesiva, Inc. (Nasdaq : ANSV)

Antares Pharma, Inc. (AMEX : AIS)

Arena Pharmaceuticals, Inc. (NasdaqGM : ARNA)

Argenes, Inc.

Argos Therapeutics

ArQule, Inc. (NASDAQ : ARQL)

Avalon Pharmaceuticals (NasdaqGM : AVRX)

Avicena Group (OTCBB : AVGO)

Avid Radiopharmaceuticals, Inc.

Avigen, Inc. (NASDAQ : AVGN)

Bayhill Therapeutics

Biodel, Inc. (NasdaqGM : BIOD)

BioMimetic Therapeutics, Inc. (NASDAQ : BMTI)

Biomira Inc. (NASDAQ : BIOM)

BioSante Pharmaceuticals (AMEX : BPA)

BioSeek, Inc.

Cadence Pharmaceuticals (NasdaqGM : CADX)

Calibrant Biosystems, Inc.

Callisto Pharmaceuticals (Amex : KAL)

Cara Therapeutics

Cardium Therapeutics (AMEX : CXM)

Catalyst Biosciences

Celator Pharmaceuticals, Inc.

Cell Genesys, Inc. (NASDAQ : CEGE)

Cell Therapeutics, Inc. (Nasdaq : CTIC)

Cellectis SA (ALCLS)

Cellerant Therapeutics, Inc.

Ceregene Inc.

Cerimon Pharmaceuticals

CG Pharmaceuticals, Inc. (KOSDAQ : 083790)

Chakshu Research

Chemokine Therapeutics Corporation (TSX : CTI)

Codexis, Inc.

Colby Pharmaceutical Company

CombinatoRx, Incorporated (NASDAQ : CRXX)

Coronado Biosciences Inc.

Curis Inc. (NASDAQ Global : CRIS)

Cyclacel Pharmaceuticals, Inc. (Nasdaq : CYCC)

Cytochroma Inc.

Cytogen Corporation (Nasdaq : CYTO)

Cytokinetics, Inc. (NASDAQ : CYTK)

CytRx Corporation (NasdaqCM : CYTR)

DermTech International

Diffusion Pharmaceuticals LLC

DiObex, Inc.

DURECT Corporation (NasdaqGM : DRRX)

Elusys Therapeutics, Inc.

Emergent BioSolutions (NYSE : EBS)

EntreMed, Inc. (NasdaqGM : ENMD)

EpiCept Corporation (NASDAQ : EPCT)

Ercole Biotech, Inc.

Exelixis, Inc. (NasdaqGS : EXEL)

EyeGate Pharmaceuticals, Inc.

Faust Pharmaceuticals SA

Favrille, Inc. (Nasdaq : FVRL)

FoldRx Pharmaceuticals, Inc.

Genaera Corporation (NASDAQ : GENR)

Genomic Health, Inc. (NasdaqGM : GHDX)

Genta Incorporated (NASDAQ : GNTA)

GenVec, Inc. (NasdaqGM : GNVC)

Geron Corporation (NasdaqGM : GERN)

GlobeImmune Inc.

GlycoMimetics, Inc.

GTC Biotherapeutics, Inc. (NASDAQ : GTCB)

Halozyme Therapeutics, Inc. (Nasdaq : HALO)

Hana Biosciences (NASDAQ : HNAB)

Hollis-Eden Pharmaceuticals, Inc. (HEPH)

Idera Pharmaceuticals, Inc. (AMEX : IDP)

IDM Pharma, Inc. (NASDAQ : IDMI)

Illumigen Biosciences, Inc.

ImaRx Therapeutics, Inc.

ImmunoGen, Inc. (Nasdaq : IMGN)

Infinity Pharmaceuticals, Inc. (NasdaqGM : INFI)

Inimex Pharmaceuticals Inc.

Innovive Pharmaceuticals Corporation (OTCBB : IVPH.OB)

Inovio Biomedical Corporation (AMEX : INO)

Insmed Incorporated (NasdaqGM : INSM)

Intercept Pharmaceuticals, Inc.

InterGenetics Incorporated

Intradigm Corporation

Introgen Therapeutics, Inc. (Nasdaq : INGN)

JJ Pharma, Inc.

Juvaris BioTherapeutics, Inc.

KAI Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc.

KineMed, Inc.

King Pharmaceuticals, Inc.

Koronis Pharmaceuticals

Kosan Biosciences Incorporated

Lev Pharmaceuticals, Inc. (OTCBB : LEVP.OB)

Lexicon Pharmaceuticals, Inc. (NASDAQ : LXRX)

Limerick NeuroSciences, Inc.

Luminex Corporation (LMNX)

M's Science Corp.

Manhattan Pharmaceuticals, Inc. (AMEX : MHA)

Marinus Pharmaceuticals Inc.

Marshall Edwards Inc. (NASDAQ : MSHL)

MediciNova, Inc. (NasdaqGM : MNOV)

Medicure Inc (AMEX : MCU)

Meditrina Pharmaceuticals, Inc.

Medivation, Inc. (Nasdaq : MDVN)

MethylGene Inc. (TSX : MYG)

Micromet, Inc. (NASDAQ : MITI)

Momenta Pharmaceuticals, Inc. (NASDAQ : MNTA)

Nanospectra Biosciences, Inc.

Nektar Therapeutics (Nasdaq : NKTR)

Neose Technologies, Inc. (NasdaqGM : NTEC)

Neotropix Inc.

NexBio, Inc.

Nile Therapeutics, Inc. (OTC : SPDU.OB)

Northfield Laboratories Inc. (Nasdaq : NFLD)

NovaDel Pharma (AMEX : NVD)

Nucleonics, Inc.

NuPathe Inc.

Nventa Biopharmaceuticals Corporation (TSX : NVN)

Oculus Innovative Sciences (Nasdaq : OCLS)

Oncolytics Biotech Inc. (TSX : ONC)

Onconova Therapeutics, Inc.

Ondine Biopharma Corporation (TSX : OBP)

Onyx Pharmaceuticals, Inc. (NasdaqGM : ONXX)

Opexa Therapeutics (Nasdaq : OPXA)

Orexigen Therapeutics, Inc. (NASDAQ : OREX)

OrthoLogic (NASDAQ : OLGC)

Osprey Pharmaceuticals Limited

Osteologix, Inc. (OLGX)

OXiGENE, Inc. (NasdaqGM : OXGN)

Pacgen Biopharmaceuticals Corporation (TSX-V : PGA)

Penwest Pharmaceuticals Co. (NasdaqGM : PPCO)

Peptech Limited / EvoGenix (ASX : PTD/ EGX)

Peregrine Pharmaceuticals Inc. (NasdaqCM : PPHM)

Phase Bioscience, Inc.

PlexPress Oy

Poniard Pharmaceuticals (Nasdaq : PARD)

Portola Pharmaceuticals, Inc.

Presidio Pharmaceuticals, Inc.

Probiodrug AG

Protalex, Inc. (OTCBB : PRTX)

Protein Sciences Corp.

Protherics PLC (LSE : PTI.L)

Protox Therapeutics Inc. (TSX-V)

PTC Therapeutics, Inc.

Quanta Fluid Solutions Ltd

QuatRx Pharmaceuticals

Receptor BioLogix

RegeneRx Biopharmaceuticals, Inc. (AMEX : RGN)

REPLICor Inc.

RHEI Pharmaceuticals

Rigel Pharmaceuticals, Inc. (Nasdaq : RIGL)

S*BIO Pte Ltd

Sangamo BioSciences, Inc. (Nasdaq : SGMO)

SemBioSys Genetics Inc.

SensiGen LLC

Serenex, Inc.

SGX Pharmaceuticals, Inc. (NASDAQ : SGXP)

Spectrum Pharmaceuticals, Inc. (Nasdaq : SPPI)

Stemedica Cell Technologies, Inc.

SuperGen, Inc. (NASDAQ : SUPG)

Surface Logix, Inc.

Synvista Therapeutics, Inc. (AMEX : SYI)

Targa Therapeutics Corporation

Targacept, Inc. (NASDAQ : TRGT)

Target Discovery, Inc.

Targeted Cell Therapies

Targeted Genetics Corporation (Nasdaq : TGEN)

Tercica (Nasdaq : TRCA)

The Dow Chemical Company (spin off - NewCo)

TOPIGEN Pharmaceuticals Inc.

Transcept Pharmaceuticals, Inc.

Twinstrand Therapeutics Inc.

Vasogen Inc. (NASDAQ : VSGN)

Venrock

VIA Pharmaceuticals (Nasdaq : VIAP)

Vical Incorporated (NASDAQ : VICL)

VioQuest Pharmaceuticals, Inc. (OTC : VQPH)

VIVUS Inc. (NasdaqGM : VVUS)

Xanthus Pharmaceuticals, Inc.

XOMA (Nasdaq : XOMA)

YM BioSciences Inc.

ZIOPHARM Oncology, Inc. (NASDAQ : ZIOP)

ZymoGenetics (NASDAQ : ZGEN)